Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice

• Asıl Yazarlar: Yu Zhang (Yazar), Yufeng Li (Yazar), Junjun Zhao (Yazar), Cong Wang (Yazar), Bin Deng (Yazar), Qilin Zhang (Yazar), Chen Shi (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Type 2 diabetes mellitus (T2DM) is a metabolic disorder with insulin resistance and impaired insulin secretion that can cause complications, including liver injury. Polyethylene glycol loxenatide (PEG-Loxe), a glucagon-like peptide-1 (GLP-1) analog, is widely used to treat T2DM. However,...